help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 2, 2006
Endocrinology, doi:10.1210/en.2006-1210
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/2/627    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Numakawa, Y.
Right arrow Articles by Numakawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Numakawa, Y.
Right arrow Articles by Numakawa, T.

Submitted on September 5, 2006
Accepted on October 24, 2006

17{beta}-Estradiol Protects Cortical Neurons against Oxidative Stress-induced Cell Death through Reduction in the Activity of Mitogen-activated Protein Kinase and in the Accumulation of Intracellular Calcium

Yumiko Numakawa, Tomoya Matsumoto*, Daisaku Yokomaku, Takahisa Taguchi, Etsuo Niki, Hiroshi Hatanaka, Hiroshi Kunugi, and Tadahiro Numakawa

Human Stress Signal Research Center (Y.N., E.N.), Neuronics Research Group, Special Division for Human Life Technology (T.M., D.Y., T.T., T.N.), National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Osaka, 563-8577, Japan; Division of Protein Biosynthesis (Y.N., T.M., D.Y., H.H., T.N.), Institute for Protein Research (IPR), Osaka University, Suita, Osaka, 565-0871, Japan; and Department of Mental Disorder Research (H.K., T.N.), National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, 187-8502, Japan

* To whom correspondence should be addressed. E-mail: Tomoya.Matsumoto{at}unibas.ch.

Although many studies have suggested that estrogen acts as a neuroprotective agent in oxidative stress, the underlying mechanism has not been fully elucidated. In the present study, we examined the effect of 17{beta}-estradiol (17{beta}-E2) on H2O2-induced death signaling in cultured cortical neurons. Exposure of the cortical neurons to H2O2 triggered a series of events including over-activation of p44/42 mitogen-activated protein kinase (MAPK) and intracellular Ca2+ accumulation via voltage-gated Ca2+ channels and ionotropic glutamate receptors, resulting in apoptotic-like cell death. The MAPK pathway might work as death signaling in our system, as the MAPK pathway inhibitor, U0126, blocked H2O2-induced MAPK activation, Ca2+ overload, and cell death. Interestingly, a similar inhibitory effect on H2O2-triggered MAPK activation, Ca2+ accumulation, and cell death was observed in cultures incubated with 17{beta}-E2 for 24 h before exposure to H2O2, suggesting that the protective effect of 17{beta}-E2 is induced via attenuating over-activation of the MAPK pathway. Furthermore, we found that ionotropic glutamate receptor subunits including NR2A and GluR2/3, but not NR2B and GluR1, were down-regulated in the 17{beta}-E2-treated cultures. The down-regulation of these glutamate receptor subunits was also observed after chronic treatment with U0126. Therefore, it is possible that 17{beta}-E2 down-regulates the expression of the ionotropic glutamate receptors by reducing activity of the MAPK pathway, which might be important for the protective effect of 17{beta}-E2 against oxidative stress-induced toxicity.


Key words: Estrogen • MAP kinase • Calcium • Ionotropic Glutamate Receptor • Cell Death




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
E. Kumamaru, T. Numakawa, N. Adachi, Y. Yagasaki, A. Izumi, M. Niyaz, M. Kudo, and H. Kunugi
Glucocorticoid Prevents Brain-Derived Neurotrophic Factor-Mediated Maturation of Synaptic Function in Developing Hippocampal Neurons through Reduction in the Activity of Mitogen-Activated Protein Kinase
Mol. Endocrinol., March 1, 2008; 22(3): 546 - 558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society